Skip Navigation

Michael F. Wolf Elected into the 2021 College of Fellows of the AIMBE

May. 11, 2021
Category: Recognition

Michael F. Wolf  ’82, ’88 was elected into the 2021 College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE), where he was nominated and recognized for his outstanding contributions toward industrial, regulatory, and international standards that assess the blood interactions and blood compatibility of medical devices and materials. Mike is a Distinguished Scientist, Bakken Fellow, and Technical Fellow in the Core Technology group of the global health care company Medtronic in Minneapolis.

Mike began his career in science as a Research Specialist at the University of Wisconsin Clinical Cancer Center (UWCCC) conducting breast cancer research and hormone receptor assays for the distinguished scientist V. Craig Jordan PhD (the ‘Father of Tamoxifen’ antiestrogen therapy). While working at the UWCCC, Mike started studying chemical engineering and launched his lifelong career focus following an independent study with chemical engineering professor and chair Stuart Cooper, where he developed an in vitro method for evaluation of immune responses in human blood upon exposure to novel medical polymers. The latter experience caught the attention of Medtronic where Mike started as a scientist in 1988 … and as they say the rest was history. With more than half of Medtronic life-saving medical devices containing a blood contacting interface, Mike has contributed to numerous product advances and new technologies. He has 10 patents, 21 peer-reviewed publications, and 6 book chapters, and he has worked in The Netherlands on a three-year expat assignment, has lead and participated in multiple local and international collaborations, and is the Convenor of the International Standard ISO10993-4 Biological Evaluation of Medical Devices: Selection of Tests for Interactions with Blood.

More Alumni Notes